title: Factors Associated with Receiving Biologics or Classic Systemic Therapy for Moderate-to-Severe Psoriasis: Evidence from the PSONET Registries.
authors.affiliation: Research Unit , Fundación Academia Española de Dermatología y Venereología, Ferraz 100, 1º izda., Madrid, Spain. pauladavilaseijo@gmail.com.
authors.forename: Paula
authors.initials: P
authors.lastname: Davila-Seijo
authors.forename: Ignacio
authors.initials: I
authors.lastname: Garcia-Doval
authors.forename: Luigi
authors.initials: L
authors.lastname: Naldi
authors.forename: Simone
authors.initials: S
authors.lastname: Cazzaniga
authors.forename: Matthias
authors.initials: M
authors.lastname: Augustin
authors.forename: Stephan J
authors.initials: SJ
authors.lastname: Rustenbach
authors.forename: Esteban
authors.initials: E
authors.lastname: Daudén
authors.forename: Tomas Norman
authors.initials: TN
authors.lastname: Dam
authors.forename: Chris
authors.initials: C
authors.lastname: Baker
authors.forename: Phyllis I
authors.initials: PI
authors.lastname: Spuls
authors.forename: Robert S
authors.initials: RS
authors.lastname: Stern
authors.forename: Arnon D
authors.initials: AD
authors.lastname: Cohen
mesh_terms: D001688:Biological Products / Q000627:therapeutic use*; D005060:Europe; D019317:Evidence-Based Medicine; D054625:Healthcare Disparities; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007557:Israel; D018579:Patient Selection; D010818:Practice Patterns, Physicians'; D011565:Psoriasis / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D012042:Registries; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D001688:Biological Products; D007166:Immunosuppressive Agents